Akebia tries for FDA approval of anemia drug after mixed data

Akebia Therapeutics is taking a chance on its closely watched pill for anemia, announcing Tuesday the submission of an application for approval to the Food and Drug Administration despite mixed study data disclosed last fall that lowered expectations for the drug.